Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
Alessandro Di Federico, Sara Stumpo, Francesco Mantuano, Andrea De Giglio, Francesca Lo Bianco, Federica Pecci, Joao V. Alessi, Xinan Wang, Francesca Sperandi, Barbara Melotti, Francesco Gelsomino, Ferdinandos Skoulidis, Marina Chiara Garassino, Solange Peters, Mark M. Awad, Andrea Ardizzoni, Biagio Ricciuti
Topics & Concepts
MedicineBlockadeInternal medicineOverall survivalPatient dataOncologyLungDual (grammatical number)Survival analysisMEDLINEClinical trialSurgeryReal world dataSurvival rateRetrospective cohort studySubgroup analysisCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsMetastasis and carcinoma case studies